Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91
Last updated 2018-06-29
Summary
The purpose of this study is to evaluate the repeated use of SYSTANE® BALANCE on stabilizing the tear film of dry eye patients with an unstable tear film.
Conditions
- Dry Eye Syndrome
- Lipid Deficiency
Interventions
- OTHER
-
SYSTANE® BALANCE eyedrops
- OTHER
-
Minims® Saline 0.9% eyedrops
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Principal Investigators
-
Michel Guillon, PhD, FCOptom, FAAO, CCTI · OTG Research & Consultancy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
More Related Trials
-
Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
NCT02380248 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
NCT02470429 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
NCT02446015 ·Status: COMPLETED ·Phase: NA
-
Systane Clinical Experience Study
NCT00818909 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392 ·Status: UNKNOWN ·Phase: NA
-
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
NCT00610480 ·Status: COMPLETED ·Phase: NA
-
Artificial Tears Study in Mild to Moderate Dry Eye Patients
NCT00607776 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Compare the Safety and Efficacy of Nanodrop®
NCT04111965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
NCT01657253 ·Status: COMPLETED ·Phase: PHASE3
-
Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355 ·Status: COMPLETED
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
NCT01198782 ·Status: COMPLETED ·Phase: PHASE4